BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 3064419)

  • 21. [Effect of immozymase inhalation on the detection of bacterial discharge in pulmonary tuberculosis].
    Krasnov VA; Kozhevnikov NN; Pletnev GV; Lisichenko GM
    Probl Tuberk; 1993; (4):42-4. PubMed ID: 8127839
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proteolytic enzymes and their inhibitors in bronchopulmonary diseases (a review of the literature)].
    Veremeenko KN; Kizim AI
    Vrach Delo; 1985 Jul; (7):34-8. PubMed ID: 3901514
    [No Abstract]   [Full Text] [Related]  

  • 23. [Possibilities of the use of immobilized proteolytic enzyme immozymase in tuberculosis].
    Krasnov VA; Kozhevnikov NN; Beliavskiĭ VE; Potashova VA; Andrenko AA; Kul'chavenia EV; Naryshkina SL; Svistel'nik AV; Grishchenko NG; Khomiakov VT
    Probl Tuberk; 1995; (3):22-5. PubMed ID: 7617627
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association of isoniazid with proteolytic enzymes in the treatment of pulmonary tuberculosis].
    Rossini G; Nessi G
    G Ital Mal Torace; 1967; 21(2):94-104. PubMed ID: 5602967
    [No Abstract]   [Full Text] [Related]  

  • 25. [Value of controlled ambulatory and clinical treatment in just discovered,TbB-positive patients during the first treatment year, as the possibilities of sputum conversion].
    Krzyśko R; Marciniak J; Zielniewicz B
    Z Erkr Atmungsorgane Folia Bronchol; 1970; 132(1):49-51. PubMed ID: 5203108
    [No Abstract]   [Full Text] [Related]  

  • 26. Proteolytic activity monitored by fluorescence resonance energy transfer through quantum-dot-peptide conjugates.
    Medintz IL; Clapp AR; Brunel FM; Tiefenbrunn T; Uyeda HT; Chang EL; Deschamps JR; Dawson PE; Mattoussi H
    Nat Mater; 2006 Jul; 5(7):581-9. PubMed ID: 16799548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effect of proteolytic and antiproteolytic activity on the pathogenesis of chronic obstructive bronchitis and pulmonary emphysema, (studies of bronchial mucus)].
    Rasche B
    Prax Pneumol; 1974 Dec; 28 Suppl():833-40. PubMed ID: 4456350
    [No Abstract]   [Full Text] [Related]  

  • 28. In vitro studies on a proteolytic enzyme from Aspergillus Oryzae (protease I).
    Ogston D; Ogston CM
    Thromb Diath Haemorrh; 1968 Mar; 19(1):136-44. PubMed ID: 4231457
    [No Abstract]   [Full Text] [Related]  

  • 29. [Protease versus antiprotease system in nasal secretion].
    Hamaguchi Y
    Nihon Jibiinkoka Gakkai Kaiho; 1983 Jan; 86(1):36-43. PubMed ID: 6341527
    [No Abstract]   [Full Text] [Related]  

  • 30. [Blood serum proteolytic activity in lung diseases].
    Bogush LK; Shvartsman LIa; Rot VS
    Probl Tuberk; 1973; 51(9):34-9. PubMed ID: 4791461
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunobiochemical evaluation of bronchoalveolar lavage (BAL) in atopic bronchial asthma, chronic bronchitis and bronchiectasis.
    Plusa T; Wäsek Z
    Allergol Immunopathol (Madr); 1987; 15(4):209-13. PubMed ID: 3318350
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysozyme, protease, and protease inhibitor proteins in fetal bovine enamel matrix extracts.
    Termine JD; Miyamoto MS; Kuettner KE
    J Dent Res; 1980 Sep; 59(9):1523-4. PubMed ID: 6995510
    [No Abstract]   [Full Text] [Related]  

  • 33. [Determination of iodine in bronchial secretion during treatment with N-cyclohexyl-N-methyl-(2-amino-3,5-dibromobenzyl)-ammonium-chloride].
    Baldamus U; Gries G
    Arzneimittelforschung; 1967 Jul; 17(7):870-1. PubMed ID: 5632847
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the problem of the treatment of bronchial tuberculosis].
    Shvartsman LIa; Fai TI; Ladnyĭ AIa
    Probl Tuberk; 1968; 46(7):44-7. PubMed ID: 5709501
    [No Abstract]   [Full Text] [Related]  

  • 35. [Possibilities for the assessment of chronic obstructive airway diseases through the analyses of bronchial mucus].
    Rasche B; Baving G; Ulmer WT
    Pneumonologie; 1973; 148(2):141-59. PubMed ID: 4198272
    [No Abstract]   [Full Text] [Related]  

  • 36. [Current concepts on the biochemistry of bronchial secretions in normal conditions and in diseases of the bronchopulmonary system].
    Kaminskaia GO
    Probl Tuberk; 1985; (5):63-71. PubMed ID: 3900987
    [No Abstract]   [Full Text] [Related]  

  • 37. Reduction of proteolytic breakdown in microbial homogenates.
    Hedman P; Gustafsson JG
    Dev Biol Stand; 1985; 59():31-9. PubMed ID: 3891464
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Epidemiological study on factors affecting the hospitalization period of patients with active tuberculosis].
    Fujino T; Fusegawa H; Nishiumi M; Okubo Y; Kakizaki T; Maejima K; Sugimori H
    Kekkaku; 2008 Aug; 83(8):567-72. PubMed ID: 18800648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Determination of the proteolytic activity of saliva].
    Beremeenko KN; Khomenko LA
    Ukr Biokhim Zh; 1973; 45(2):223-6. PubMed ID: 4709891
    [No Abstract]   [Full Text] [Related]  

  • 40. A modified fibrin plate for rapid detection of proteinases and proteinase inhibitors in fractions after liquid chromatography.
    Safarík I
    J Biochem Biophys Methods; 1988 Dec; 17(4):277-83. PubMed ID: 3072361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.